Sensititre ® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 3, 2016, Pages 329-334

  Yu, X ^a   Ma, Y F ^a   Jiang, G L ^a   Chen, S T ^a   Wang, G R ^a   Huang, H R ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

DST; M. tuberculosis; MYCOTB plate; REMA

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BIOASSAY; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEASIBILITY STUDY; INTERMETHOD COMPARISON; LOWENSTEIN JENSEN PROPORTION METHOD; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; MYCOBACTERIUM TUBERCULOSIS TEST KIT; NONHUMAN; PRIORITY JOURNAL; RESURAZINE MICROTITER ASSAY; CHINA; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; TUBERCULOSIS;

AMIKACIN; AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; CHINA; CYCLOSERINE; ETHAMBUTOL; HUMANS; ISONIAZID; KANAMYCIN; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; RIFAMPIN; TUBERCULOSIS;

EID: 84958549435     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0573     Document Type: Article

References (25)

1. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
2. Lyu J, KimMN, Song JW, et al. GenoType® MTBDR plus assay detection of drug-resistant tuberculosis in routine practice in Korea. Int J Tuberc Lung Dis 2013; 17: 120-124.
3. Ling D I, Zwerling A A, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a metaanalysis. Eur Respir J 2008; 32: 1165-1174.
4. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640.
5. Banada P P, Sivasubramani S K, Blakemore R, et al. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J Clin Microbiol 2010; 48: 3551-3557.
6. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010; 48: 2495-2501.
7. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl JMed 2010; 363: 1005-1015.
8. Mokaddas E, Ahmad S, Eldeen H S, et al. Discordance between Xpert MTB/RIF and BACTEC MGIT 960 culture system for detection of rifampin-resistant Mycobacterium tuberculosis isolates in a low TB incidence country. J Clin Microbiol 2015; 53: 1351-1354.
9. Mathys V, van de Vyvere M, de Droogh E, et al. False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene. Int J Tuberc Lung Dis 2014; 18: 1255-1257.
10. Lee J, Armstrong D T, SsengoobaW, et al. Sensititre MYCOTB MIC Plate for testing Mycobacterium tuberculosis susceptibility to first-and second-line drugs. Antimicrob Agents Chemother 2014; 58: 11-18.
11. Hall L, Jude K P, Clark S L, et al. Evaluation of the Sensititre MYCOTB Plate for susceptibility testing of the Mycobacterium tuberculosis complex against first-and second-line agents. J Clin Microbiol 2012; 50: 3732-3734.
12. Abuali M M, Katariwala R, LaBombardi V J. A comparison of the Sensititrew MYCOTB Panel and the agar proportion method for the susceptibility testing of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2012; 31: 835-839.
13. World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2014.11. Geneva, Switzerland: WHO, 2014.
14. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2008.402. Geneva, Switzerland: WHO, 2008.
15. KohWJ, Lee S H, Kang YA, et al. Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2013; 188: 858-864.
16. Isaeva Y, Bukatina A, Krylova L, et al. Determination of critical concentrations of moxifloxacin and gatifloxacin for drug susceptibility testing of Mycobacterium tuberculosis in the BACTECe MGITe 960 system. J Antimicrob Chemother 2013; 68: 2274-2281.
17. Banu S, Rahman S M, Khan M S, et al. Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. J Clin Microbiol 2014; 52: 156-163.
18. Palomino J C, Martin A, Camacho M, et al. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002; 46: 2720-2722.
19. Martin A, Camacho M, Portaels F, et al. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003; 47: 3616-3619.
20. Dixit P, Singh U, Sharma P, et al. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. J Microbiol Methods 2012; 88: 122-126.
21. Hung WY, Yu MC, Chiang Y C, et al. Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in northern Taiwan. Int J Tuberc Lung Dis 2014; 18: 601-606.
22. Madison B, Robinson-Dunn B, George I, et al. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol 2002; 40: 3976-3979.
23. Schon T, Jureen P, Giske C G, et al. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. J Antimicrob Chemother 2009; 64: 786-793.
24. Yu X, Jiang G, Li H, et al. Rifampin stability in 7h9 broth and Löwenstein-Jensen medium. J Clin Microbiol 2011; 49: 784-789.
25. Leonard B, Coronel J, Siedner M, et al. Inter-and intra-assay reproducibility of microplate alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2008; 46: 3526-3529.